SCHEMBL534062

SCHEMBL534062

COc1ccc(C)cc1S(=O)(=O)Nc1c(C)cc(C)c(N2CCCC2)c1C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ERAP1 Q9NZ08 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.51
KMT2A Q03164 4/20 0.51
MEN1 O00255 3/20 0.51
TSHR P16473 2/20 0.51
LMNA P02545 2/20 0.49
RECQL P46063 1/20 0.49
CASP1 P29466 2/20 0.48
TP53 P04637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
USP2 O75604 1/20 0.48
GAA P10253 1/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 1/20 0.47
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532936 0.91 MCOLN3 (0.51) ERAP1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL532935 0.90 ALDH1A1 (0.53) SMN1; SMN2KMT2AMEN1LMNARECQL
SCHEMBL14288678 0.89 ALDH1A1 (0.52) SMN1; SMN2KMT2AMEN1TSHRLMNA
SCHEMBL534065 0.89 PKM (0.53) SMN1; SMN2KMT2AL3MBTL1GAA
SCHEMBL533016 0.86 ALPL (0.49) ERAP1TSHRTP53L3MBTL1ALDH1A1
SCHEMBL533112 0.84 ALPL (0.46) ERAP1KMT2AMEN1TSHRRECQL
SCHEMBL533460 0.84 ALDH1A1 (0.42) ERAP1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL532832 0.83 FFAR4 (0.60) SMN1; SMN2TSHRLMNATP53ALDH1A1
SCHEMBL533957 0.81 TP53 (0.39) ERAP1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL533017 0.79 FFAR4 (0.55) SMN1; SMN2KMT2AMEN1LMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed